An appearance by a pro-life activist on CNN did not last very long.

On Thursday, Kristan Hawkins, the president of Students For Life of America, was interview by CNN’s Jim Acosta to discuss the Supreme Court’s decision to allow hospitals in Idaho to perform emergency abortions.

“Well, I think President Trump and the GOP needs to take note. The Biden administration continues to make the case to weaponize federal agencies to make abortion a federal issue. But we also see a silver lining in this decision today,” Hawkins responded.

She went on:

“If Idaho, while this is tragic, saying Idaho must allow for abortions to prevent infertility, future infertility, the FDA must now change its policy too to do the same. Given their no-test online distribution scheme of chemical abortion pills, which we know harm women’s future fertility, as 15% of women of our population are RH negative, and there is no testing now because of the Biden administration and their FDA on these dangerous chemical abortion pills that she’s having these pill abortions. She’s not being tested for RH negative status…”

However, Acosta interjected, “Haven’t the experts said that mifepristone is safe for women to use?”

Watch the video below:

Hawkins shot back, “Ask any woman who’s RH negative. Ask any woman. Excuse me? Ask someone who’s been pregnant, sir! When you’re pregnant, one of the first things they do is they test for RH negative status. Because if you have a miscarriage, if you give birth… If you have an abortion, you have to be treated immediately.”

“I’m sorry, mifepristone has been proven to be safe. It’s been that way for years. But thank you for coming on. We appreciate it,” Acosta said.

As Hawkins protested, the anchor ended the interview, saying, “We want to go to a quick break. Thank you very much. We’ll be right back.

A report by The New York Times reviewed academic studies and found the majority of them have determined chemical abortion pills do not pose a significant health risk.

However, conservatives argue those studies are not necessarily accurate due to policy changes at the FDA under the Biden Administration they believe will lead to increased risks associated with the pills, such as allowing people who are not physicians to prescribe and administer the pills